ITeos Therapeutics Inc (ITOS)
11.01
+0.23
(+2.13%)
USD |
NASDAQ |
Apr 23, 16:00
11.01
0.00 (0.00%)
After-Hours: 17:54
ITeos Therapeutics Debt to Equity Ratio
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
Date | Value |
---|---|
March 31, 2023 | 0.00 |
December 31, 2022 | 0.00 |
September 30, 2022 | 0.00 |
June 30, 2022 | 0.00 |
Date | Value |
---|---|
March 31, 2022 | 0.00 |
December 31, 2021 | 0.00 |
September 30, 2021 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
Sep 2021
--
Maximum
Sep 2021
--
Average
--
Median
Sep 2021
Debt to Equity Ratio Benchmarks
Gilead Sciences Inc | 1.094 |
Merck & Co Inc | 0.9328 |
Arcus Biosciences Inc | 0.00 |
IGM Biosciences Inc | 0.00 |
Forian Inc | 0.95 |
Debt to Equity Ratio Related Metrics
Total Assets (Quarterly) | 667.59M |
Total Liabilities (Quarterly) | 92.36M |
Shareholders Equity (Quarterly) | 575.23M |